These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30624772)

  • 1. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
    Wong GN; Shen S; Nixon R
    Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
    Nakada T; Matsuzawa Y
    Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
    Arikawa J; Okabe S; Kaneko T
    J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
    [No Abstract]   [Full Text] [Related]  

  • 5. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
    Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
    Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
    Proske S; Uter W; Schnuch A; Hartschuh W
    Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 8. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
    Kurumaji Y
    Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
    Gniazdowska B; Ruëff F; Przybilla B
    Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufexamac is a frequent contact sensitizer.
    Kränke B; Derhaschnig J; Komericki P; Aberer W
    Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
    Koch P; Bahmer FA
    Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
    Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
    Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
    Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
    Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis from bufexamac cream.
    Corazza M; Roveggio C; Virgili A
    Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe contact dermatitis caused by bufexamac with large flap desquamation].
    Landrieux C; Estève E; Serpier H; Kalis B
    Ann Dermatol Venereol; 1996; 123(3):198-9. PubMed ID: 8761786
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact allergy to benzyl salicylate.
    Fernández-Canga P; Ruíz-González I; Varas-Meis E; Valladares-Narganes LM; Rodríguez-Prieto MA
    Contact Dermatitis; 2017 May; 76(5):315-316. PubMed ID: 28386976
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic contact dermatitis presenting as severe and persistent blepharoconjunctivitis and centrofacial oedema after dyeing of eyelashes.
    Vogel TA; Coenraads PJ; Schuttelaar ML
    Contact Dermatitis; 2014 Nov; 71(5):304-6. PubMed ID: 25345792
    [No Abstract]   [Full Text] [Related]  

  • 19. Contact dermatitis from soybean extract in a cosmetic cream.
    Shaffrali FC; Gawkrodger DJ
    Contact Dermatitis; 2001 Jan; 44(1):51-2. PubMed ID: 11156026
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact allergy to topical diclofenac with systemic tolerance.
    Beutner C; Forkel S; Kreipe K; Geier J; Buhl T
    Contact Dermatitis; 2022 Jan; 86(1):41-43. PubMed ID: 34423444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.